Functional Resistance Assay

The assay links treatment exposure to a measurable cellular response by comparing treated samples with untreated controls. Viability, proliferation, or another functional readout shows whether cells continue surviving or expanding under the tested condition. This direct comparison can reveal drug effects that genetic predictions alone may not capture.

Defined concentrations create consistent conditions for comparing cellular responses to treatment. Examining changes at the tested levels can distinguish stronger, weaker, or partial responsiveness rather than relying on a single exposure. This helps characterize treatment-specific vulnerability and identify samples containing cells that remain functionally active despite drug exposure.

Resistant populations indicate that some cancer cells can withstand the tested treatment, while partially responsive populations show an incomplete reduction in cellular activity. These patterns provide functional evidence of mixed treatment responses within a sample. They can guide investigations into resistance mechanisms and help identify vulnerabilities that may differ between therapies.

A typical workflow begins with tumor cells or a patient-derived sample, followed by exposure to defined drug concentrations. Researchers then quantify changes in viability, proliferation, or another functional characteristic and compare those measurements with untreated controls. The resulting comparison identifies the degree of response and highlights resistant or partially responsive cellular behavior.

The approach can use tumor cells or patient-derived samples, depending on the research question. Functional outcomes may be assessed through changes in cell viability, proliferation, or other measured cellular responses. Selecting a readout that reflects treatment-related cellular behavior allows researchers to compare samples and evaluate how strongly each responds to the tested drug.

In cancer research, the assay supports studies of treatment resistance, candidate therapy evaluation, and treatment-specific vulnerabilities. Because it measures cellular behavior directly, results can complement genetic predictions during drug-response investigations. Findings may also contribute to personalized treatment strategies by showing how an individual patient-derived sample functionally responds to a tested therapy.